Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir for Prevention of HBV Mother-to-child Transmission
NCT02937779Phase 4Unknown
- Sponsor
- ANRS
- Start
- Oct 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by ANRS. Primary endpoint: Proportion of active HBV infection in new-born at 6 months of life. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02937779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02937779.